Member Info for Bluebelly

There are different requirements for listing different stocks. I guess we would come under the Assets & Equity type.
'Standard No. 4: Assets With Equity
Companies can eliminate the cash flow and revenue requirements, and decrease its marketing capitalization requirements to $160 million if their total assets total at least $80 million and their stockholders' equity is at least $55 million.'

It's not clear whether we are approved for listing yet/ still in discussion/ or it's happening??

BB

And volume looks to be good!

BB

Some Brokers are still distributing the shares manually apparently.
So trading cannot commence until this is complete.

BB

Denny11: It follows a Friday rise in the US on fairly small volumes.

The volume has only been above that level about 4 or 5 times this year.

BB

Lampard8: Thanks for the reply. 60% down is not uncommon, but hard to accept. I have my ISA that is 50% down (with 30k Accustem to come) and my wife ISA 30% down and no Accustem. I do not believe you will be waiting 2 years to recover your loses and turn a profit. Some things that we are waiting on in the near term .

The first patient with SPMS was dosed on May 24, 2021 with nasally administered Foralumab. The treatment regimen will continue for six months to examine long-term safety, tolerability and clinical responses. - 9 Weeks of data.

Tiziana Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma. - RNS'd over 11weeks ago.

Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab. to conduct a Phase 2 Proof-of-concept study in Brazil to evaluate the safety, tolerability and efficacy of intranasal Foralumab in hospitalized patients with severe coronavirus disease 2019 (COVID-19) and pulmonary inflammation. Nearly 5 weeks ago.

And Acustem will hopefully be on a separate board in the not to distant future. Jul/Aug ish.

Also:
Hopefully H2 will give us a slow climb to POC for Foralumab & the SP will re-rate to maintain a higher trading range.

GLA

BB

Plan2RetireEarly: 'the BOD are carefully cultivating those roots and one day this will be the fastest growing plant in this insect infested jungle.'

I believe Foralumab is not only a treatment for Covid and many other illnesses, but it also works on plants in an insect infested jungle. 'The Holy Grail'

BB

Blue83: Luckily for TILS the cash in the bank is still worth $1/$1. Unfortunately for GC his £10m bonus is now only worth £3m. Not that I feel sorry for him.
Thanks for pointing this out, it looks like a great time to get onboard.

BB

Lampard8: would love that to be true but based on what?
It is true - Yahoo Finance chart - Live price= $2.04 (12% up)
Did you respond to the wrong title?

BB

Hopefully the low has been hit this week and it's a rise to true value.

BB

Sustitute asterix's for: t. me / joinchat /
Remove all spaces.

BB

AO: 'every time TILS peaks, it then drops right down to a long low.' - Are you posting to say you don't hold because of that scenario?
That's why they're called peaks, most stocks will climb quicker than they fall, unless bad news is released. The pharma stocks have been hit hard generally, some harder than others.
Hopefully H2 will give us a slow climb to POC for Foralumab & the SP will re-rate to maintain a higher trading range. Lots of other news could come prior to that!

BB

Roger65: 'Either way, I'd be delighted with anything over £1.50. £2.50 would be pretty extraordinary from where we are currently sitting so regrettably I think that's not feasible, is it?

12 month highs of the three spikes are £3 high, £2.60 close - High & Close 32.04 - £1.95 & £1.76. So they would have to make an offer in excess of these highs . The last one being late Jan.

BB

It's not confirmed anything yet. But it closed at $1.84, after the double bottom.

BB

At this time I would prefer 20000 Tils to 30000 Accustem.

BB

That sounds good.
On 30,000 shares, I would get 20,000 TILS (£12400).That's jus over 40p/ Accustem share.

BB

Apologies $1.76

Can it turn around now?

BB

nofear52, You may want to change your moniker!
That's a big loss on 100k shares bought in April.
Good luck on recovering it back elsewhere.

BB

Can you expand on why TILS would be so expensive.

BB

Pipeline valued at around £100m after removing cash.
An 8 bagger to be bought out for £1b.
I'll hang in here, and buy more in Aug 21.
Remember how the board has been strengthened. I'm guessing some performance options will be dished out to the board at this low price with targets to hit at £2, £3.50, £5.

BB